APOE and Alzheimer disease: BrainAGE was significantly different across controls, MCI, and AD subjects. BrainAGE correlated with neuropsychological scores in APOEe4 carriers and non-carriers. BrainAGE acceleration was observed in progressive MCI and AD subjects and brainAGE correctly predicted conversion of MCI to AD even without APOE genotype.